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forces as well as the general shape of kinematics’ curves were
also compared with in vivo curves described in the literature.
Results: Data recorded during in vitro simulations highlighted
average intra-specimen variability less than 0.8° and 0.7 mm
for the three rotations and translations of the stiﬂe respectively,
compared with 5.8° and 1.3 mm for the inter-specimen variability.
The comparison of the six average curves of movements collected
on the tested stiﬂes to those from in vivo trials reveals similar
patterns in every case. However, amplitude of movement is slightly
greater on in vivo curves. Peak vertical forces measured in the
device (138±2 N) were also similar to in vivo trials reported in the
literature.
Conclusions: Results show that the device generates reliable
motion on a loaded limb which are representative of the in vivo
3D kinematics presented in the literature. The validation of the
model is the ﬁrst step to understanding the inﬂuence of OA on
3D kinematics. This model could be adapted and used with the
human knee in ex vivo studies.
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Purpose: Rotator cuff tears of the shoulder are a common cause
of pain, disability and shoulder osteoarthritis. The surgical re-
constructive procedures for rotator cuff tears present a number of
limitations. The few studies in which the repair integrity is evaluated
have shown the existence of a high rate of re-ruptures in spite of
the fact that the short-term functional results are satisfactory. Mor-
phologic analysis of the sutures, after different follow-up periods,
has not shown satisfactory results. Therefore, giving the relatively
poor result of surgical intervention, new approaches need to be
developed. In this study, we have established an animal model
of chronic rotator cuff tears to study supraspinatus (SE) tendon
characteristics at the insertion site as occurs in human pathology.
Methods: Unilateral surgery was performed in 18 mature rats
(9 months old) to detach the SE tendon insertion sites. Under
aseptic operating room protocols, deltoid muscle was detached
sharply from acromion. The SE was visualized and then exposed
by external rotation of the humerus, SE was detached sharply at
the bone insertion site. Fibrocartilage was removed at the insertion
site by scraping with a scalpel blade and SE tendon was allowed
to freely retract. The overlying deltoid muscle and skin was closed.
Contralateral shoulder was used as a control. Rats were sacriﬁed
at 1 month (n=6), 2 month (n=6) and 4 month (n=6) post-injury.
- Histologic analysis: the natural healing response was evaluated
by quantitative collagen ﬁber orientation. 5μm sections from the
injured shoulder of three animals in each group were stained
with hematoxylin and eosin. SE muscle and tendon, the proximal
humerus, and any scar tissue that ﬁlled the tendon-bone defect
were included into the sections. Collagen organization analysis
was evaluated using a quantitative polarized light microscopy.
- Biomechanical analysis: Remaining three specimens in each
group were used for biomechanical analysis. SE was isolated
by detaching the tendon and muscle from all surroundings tis-
sues. Each specimen were then immersed at 39°C, preloaded to
0.1Newtons (N), preconditioned for 10 cycles from 0.1 to 0.5N at
a rate of 3%/s, and held for 300s. Just following that, a stress
relaxation experiment was performed. Ramp to failure was then
applied at a rate of 0.3%/s. Tendon-humerus specimens were
performed with the specimen at 90 degrees of abduction in an
electro mechanic Instron 5866 machine.
Results: Control specimens showed a normal four-zone tendon-
bone transition consisting of tendon, ﬁbrocartilage, mineralized
ﬁbrocartilage and bone. The injury model did not show any of
these zones and tendon defect remains unﬁlled and/or partially
disrupted; collagen organization was also disrupted in the injury
model. This tendon mimics tendon appearance of human chronic
rotator cuff tears.
Biomechanical tests showed that maximum resistance, previous to
rupture, in the control group was 38Newtons (N). In contrast, only
a minimal resistance, less than 5N in all cases, was observed in
the case of injury model. Also in all cases, tendon rupture during
mechanical test occurred at the tendon-bone insertion site. No
signiﬁcant differences were observed in histological or mechanical
tests at 1, 2 and 4 months.
Conclusions: These data suggest that our rat model of rotator
cuff disease is an appropriate in vivo animal model to study
chronic rotator cuff disease. Different suture approaches together
with BMPs, growth factors and/or Mesenchymal Stem Cells could
be easily tested in this model in order to obtain a much better heal
of tendon and to prevent secondary shoulder osteoarthritis.
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Purpose: Osteoarthritis (OA) is a chronic degenerative disease
characterized by progressive loss of articular cartilage, subchon-
dral bone sclerosis, osteophyte formation and changes in the
synovial lining. Due to the localized nature of the disease, dosing
therapeutics intra-articularly (IA) is an attractive delivery approach
for OA, and it is already established in the clinic for delivering
corticosteroids and viscosupplements. To deliver a biologic or a
recombinant protein IA, it is important to know how long the
molecule will be retained in the joint. The purpose of this research
was to assess the pharmacokinetics of a monoclonal antibody in
the knee joint following IA and systemic delivery to normal rats.
Methods: A non-speciﬁc monoclonal antibody not known to cross-
react with rat protein was injected IA into the knee joint or intraperi-
toneally (ip) into normal Sprague Dawley rats. Synovial ﬂuid knee
lavage and serum samples were collected at various time periods
following dosing and antibody concentrations were determined by
ELISA. To control the dilution of synovial ﬂuid from the lavage,
antibody levels in the lavage were normalized by measuring and
comparing urea concentrations in the lavage and serum. To un-
derstand the distribution of antibody in joint tissues, radiolabeled
antibody was injected IA and joint (including bone, cartilage and
synovium), synovial ﬂuid lavage, and blood samples were col-
lected at various time-points. Radioactivity in the tissue and body
ﬂuid samples was measured by scintillation counting. Finally, two
radiolabeled antibodies were dosed IA and compared for their
retention in the joint after 10 minutes and 24 hours by the method
described above. One antibody was non-speciﬁc and not known
to cross-react with rat while the other was speciﬁc to rat type II
collagen.
Results: We demonstrated that approximately 5% of the non-
speciﬁc antibody could be detected in the synovial ﬂuid 12 hours
after ip administration to normal rats. Following IA dosing, the
non-speciﬁc antibody was cleared from the synovial ﬂuid and the
joint tissue with a half-life in the range of 8-9 and 12 hours, respec-
tively. Approximately 20% of the non-speciﬁc antibody appeared
in the blood 24 hours post IA dosing. Signiﬁcantly higher levels
